Genetic variation in radiation-induced expression phenotypes.
Studies have demonstrated that natural variation in the expression level of genes at baseline is extensive, and the determinants of this variation can be mapped by a genetic-linkage approach. In this study, we used lymphoblastoid cells to explore the variation in radiation-induced transcriptional changes. We found that, among normal individuals, there is extensive variation in transcriptional response to radiation exposure. By studying monozygotic twins, we demonstrated that there is evidence of a heritable component to this variation. The postradiation variation in the expression level of several genes, including the ferredoxin reductase gene (FDXR) and the cyclin-dependent kinase inhibitor 1A gene (CDKN1A), is significantly greater (P<.001) among twin pairs than within twin pairs. The induction of FDXR by radiation showed a bimodal distribution. Our findings have important implications for understanding the genetic basis of radiation response, which has remained largely unknown due to the lack of family material needed for genetic studies. Our approach, which uses expression phenotypes in cell lines, allows us to expose cells from family members to radiation. Similar study design can be applied to dissect the genetic basis of other complex human traits.
Correa
Candace R
CR
School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cheung
Vivian G
VG
D018797:Cell Cycle Proteins / Q000378:metabolism; D002478:Cells, Cultured; D016000:Cluster Analysis; D050759:Cyclin-Dependent Kinase Inhibitor p21; D005287:Ferredoxin-NADP Reductase / Q000378:metabolism; D015870:Gene Expression / Q000528:radiation effects*; D014644:Genetic Variation / Q000528:radiation effects*; D006801:Humans; D010641:Phenotype; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014158:Transcription, Genetic / Q000528:radiation effects*; D014427:Twins
C493956:CDKN1A protein, human; D018797:Cell Cycle Proteins; D050759:Cyclin-Dependent Kinase Inhibitor p21; D005287:Ferredoxin-NADP Reductase